I mean, hopefully they are shortening effective patent terms - that’s the whole point of maintenance fees!
Posts by Luis Gil Abinader
War Undersecretary Emil Michael says that Claude would "pollute" defense supply chain because, like all major models, it has its own model spec. The argument seems to be that if Claude has any constraints that go beyond "whatever is legal," that constitutes contamination of the defense supply chain.
Screenshot of a Federal Register notice from the Department of Commerce, Patent and Trademark Office, Docket No. PTO-C-2025-0018, titled 'Request for Comments on the World Intellectual Property Organization Riyadh Design Law Treaty.' The notice includes the agency, action, summary, dates, and addresses sections. Scheduled for publication on 03/13/2026.
The USPTO is seeking public input on whether the U.S. should join the WIPO Riyadh Design Law Treaty (RDLT).
www.federalregister.gov/public-inspe...
Pharmaceutical companies will probably argue that drug discovery and clinical trial work done in the U.S. is a product “component.”
PTO Director flat-out says he plans to discriminate against foreign companies (patent owners AND challengers) in deciding whether to allow IPR petitions. It's time to admit that the "unreviewable discretion" the statute gives the Director didn't have rogue agents like him in mind
aboutblaw.com/bk9y
USPTO Director Squires today issued a new memo introducing domestic manufacturing as a discretionary factor in deciding whether to institute inter partes review and post-grant review proceedings. The Director will consider whether "assembly of the final product" or "components" are made in the U.S.
New research by Pierre Azoulay, Danielle Li, Bhaven Sampat and me.
Earlier this year, the President’s budget proposed a 40% cut to the budget of the NIH. This motivated us to ask: what if the NIH had been 40% smaller?
Cool new research digs into 💉 purchasing contracts that pharma negotiated with South Africa
Here's what they found:
@hji-sa.bsky.social @abinader.bsky.social @matthewkavanagh.bsky.social
BREAKING: Tesla was just hit with a $329 million verdict in a trial over a fatal crash that a Miami jury found was caused by Tesla's defective autopilot.
Can voluntary deals ensure equitable vaccine access in a pandemic? Our new research w @hji-sa.bsky.social
on South Africa’s COVID-19 negotiations shows no. Major policy made via private contract. Implications for global governance... 🧵
doi.org/10.1080/1744...
@abinader.bsky.social
Another new #NIH Notice published today. In addition to the AI information referenced below, NIH is also instituting a new policy limiting the number of applications that NIH will consider per Principal Investigator per calendar year. It's included in this Notice. #RAdminsky #Research #Medsky
NIH issues new policy stating that it will not consider research grant applications “substantially developed” by AI to be original ideas of the applicant.
grants.nih.gov/grants/guide...
The co-founder of Palantir is backing a construction automation startup seeking to build AI powered heavy machinery that doesn't require workers.
The company, Bedrock Robotics, was founded by three people who used to work at Waymo.
www.benzinga.com/markets/tech...
why Purple Patch?
Article by @abinader.bsky.social on the efforts to address late disclosures of federal funding in US patents.
academic.oup.com/jlb/article/...
Independent Articles Global Legal Environment for LGBTQ+ Sexuality and Public Health Matthew M. Kavanagh1,2 , Varsha Srivatsan2, Florence Riako Anam3, Ludo Bok4, Luis Gil Abinader2, Agrata Sharma2 , Catherine Grant4, Yu Wei Chen2 and Sharonann Lynch2 1Georgetown University, Washington, DC USA; 2Center for Global Health Policy & Politics, O’Neill Institute for National and Global Health Law, Washington, DC USA; 3Global Network of People Living With HIV, Nairobi, Kenya and 4United Nations Development Programme, New York, USA Abstract In 2023 the Supreme Court of Mauritius cited human rights and public health arguments to strike down a colonial-era law criminalizing consensual same-sex sex. The parliament of Singapore recently did the same through legislative means. Are these aberrations or a shifting global consensus? This article documents a remarkable shift international legal shift regarding LGBTQ+ sexuality. Analysis of laws from 194 countries across multiple years demonstrates a clear, ongoing trend toward decriminalization globally. Where most countries criminalized same-sex sexuality in the 1980s, now two-thirds of countries do not criminalize under law. Additionally, 28 criminalizing countries in 2024 demonstrate a de facto policy of non-enforcement, a milestone towards legal change that all of the countries that have fully decriminalized since 2017 have taken. This has important public health effects, with health law lessons for an era of multiple pandemics. But amidst this trend, the reverse is occurring in some countries, with a counter-trend toward deeper, harsher criminalization of LGBTQ+ sexuality. Case studies of Angola, Singapore, India, Botswana, Mauritius, Cook Islands, Gabon, and Antigua and Barbuda show many politically- and legally-viable pathways to decriminalization and highlight actors in the executive, legislative, and judicial arenas of government and civil society engaged in legal change. Keywords: LGBT health; human rights; discrimination; …
Now open access on FirstView: "Global Legal Environment for LGBTQ+ Sexuality and Public Health" by @matthewkavanagh.bsky.social, @abinader.bsky.social, @sharonannlynch.bsky.social and team. The article analyzes politically and legally viable pathways to decriminalization. #LGBTHealth #HIV #LGBTQIA
Earlier, 2023, memorandum to HHS on measures to include data on the costs of trials in ClinicalTrials.Gov
www.keionline.org/40783
That's not to say that pharma won't try to - as ever - keep prices secret.
Monthly re-upping of one of my top 5 favourite papers ever by @cmorten.bsky.social on why trade secret protections are often more vibes than actual law : papers.ssrn.com/sol3/papers.cfm?abstract_id=4041556 7/8
We just posted a major new study of AI models and books, showing that some (but not all) models memorize large portions of some (but not all) books after training on the books3 database
With A. Feder Cooper and Amy Cyphert, among others
arxiv.org/pdf/2505.12546
Patent post expiry royalties return to SCOTUS.
Blog by @denniscrouch.bsky.social with link to the Atrium Medical cert petition: patentlyo.com/patent/2025/...
Symposium Law and Global Governance of Infectious Disease: Access to Medicines on COVID-19, AIDS, and Beyond Matthew M. Kavanagh1,2 , Luis Gil Abinader1,2, Fatima Hassan2 and Eric Friedman3 1Center for Global Health Policy & Politics, Georgetown University, Washington, District of Columbia, United States; 2Health Justice Initiative, Cape Town, South Africa and 3O’Neill Institute, Georgetown University, Washington, District of Columbia, United States Abstract Scientific advances to fight infectious diseases have been remarkable. International law and global governance have sought, and often failed, to keep pace, secure equity, and stop outbreaks. We trace the law and governance model emerging from early failure in the AIDS response and identify four elements: use of law by national governments to compel sharing; decentralized generic manufacturing; mechanisms for voluntary sharing of patents and technology transfer; international funding. In combination, these created a remarkable new ecosystem. We find that when COVID-19 hit and mRNA vaccines were rapidly developed, global North governments opposed mobilizing this synergistic model. Instead, equity efforts focused on financing purchase of vaccines from originator companies with little use of law. Amidst monopolies and scarcity of doses, vaccine nationalism fatally undermined this effort. Whether more synergistic law and governance emerges from rapidly changing global health law will likely dictate the efficacy of future global infectious disease response. Keywords: COVID; AIDS; health law; intellectual property
Now on FirstView: "Law and Global Governance of Infectious Disease: Access to Medicines on COVID-19, AIDS, and Beyond" by @matthewkavanagh.bsky.social, @abinader.bsky.social, Fatima Hassan, and Eric Friedman.
#COVID #AIDS #HealthLaw
www.cambridge.org/core/journal...
The Trump administration's push to dismantle #USAID undermines U.S. foreign policy & global health, argued @matthewkavanagh.bsky.social and @abinader.bsky.social. "This is neither good policy nor legal under the most basic elements of U.S. law and the Constitution.” foreignpolicy.com/2025/02/04/u...
NIH is ending billions of dollars in foreign subawards, jeopardizing thousands of projects on infectious diseases, cancer and more.
Unless foreign researchers secure funding directly from NIH by October — a tall order for any researcher — clinical trials abroad and other research will shut down.
Out today in @jama.com, a joint warning from AEREO, @weareprimr.bsky.social, @aahrpp.bsky.social, and CARE-Q, about how capped indirects and decimation of OHRP risk slowing research and making participants less safe.
jamanetwork.com/journals/jam...
My panel with @daniel-solove.bsky.social, @mariotrujillo.bsky.social, and @alexreevegivens.bsky.social on DOGE, the Privacy Act, and how to protect privacy in our new authoritarian regime can be viewed here:
www.youtube.com/watch?v=j6eQ...